Human neonatal naive CD4+; T Cells have enhanced activation-dependent signaling regulated by the MicroRNA miR-181a

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2682-2691

  Palin, Amy C ^a   Ramachandran, Vasavi ^a   Acharya, Swati ^a   Lewis, David B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD28 ANTIGEN; CD3 ANTIGEN; MICRORNA; MICRORNA 181A; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMOCYTE; UMBILICAL CORD BLOOD;

CALCIUM SIGNALING; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; MICRORNAS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84874875967     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202534     Document Type: Article

References (65)

1. Lewis, D. B., and C. B.Wilson. 2011. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In Infectious Diseases of the Fetus and Newborn, 7th Ed. J. O. Klein, Y. Maldonado, V. Nizet, J. S. Remington, and C. B.Wilson, eds. Elsevier Saunders, Philadelphia, p. 80-191
2. Burchett, S. K., L. Corey, K. M. Mohan, J. Westall, R. Ashley, and C. B. Wilson. 1992. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J. Infect. Dis. 165: 813-818
3. Sullender, W. M., J. L. Miller, L. L. Yasukawa, J. S. Bradley, S. B. Black, A. S. Yeager, and A. M. Arvin. 1987. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis. 155: 28-37
4. Smith, S., R. F. Jacobs, and C. B. Wilson. 1997. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J. Pediatr. 131: 16-26
5. Alcaïs, A., C. Fieschi, L. Abel, and J.-L. Casanova. 2005. Tuberculosis in children and adults: two distinct genetic diseases. J. Exp. Med. 202: 1617-1621
6. Rocha, V., J. E. Wagner, Jr., K. A. Sobocinski, J. P. Klein, M. J. Zhang, M. M. Horowitz, and E. Gluckman; Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. 2000. Graft-versus-host disease in children who have received a cordblood or bone marrow transplant from an HLA-identical sibling. N. Engl. J. Med. 342: 1846-1854
7. Ballen, K. K., and T. R. Spitzer. 2011. The great debate: haploidentical or cord blood transplant. Bone Marrow Transplant. 46: 323-329
8. Wolf, D., M. von Lilienfeld-Toal, A. M. Wolf, M. Schleuning, M. von Bergwelt- Baildon, S. A. E. Held, and P. Brossart. 2012. Novel treatment concepts for graftversus- host disease. Blood 119: 16-25
9. Chen, L., A. C. Cohen, and D. B. Lewis. 2006. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol. Blood Marrow Transplant. 12: 160-171
10. Nonoyama, S., L. A. Penix, C. P. Edwards, D. B. Lewis, S. Ito, A. Aruffo, C. B. Wilson, and H. D. Ochs. 1995. Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95: 66-75
11. Jullien, P., R. Q. Cron, K. Dabbagh, A. Cleary, L. Chen, P. Tran, P. Stepick-Biek, and D. B. Lewis. 2003. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation. Int. Immunol. 15: 1461-1472
12. Cantó, E., J. L. Rodríguez-Sánchez, and S. Vidal. 2005. Naive CD4+ cells from cord blood can generate competent Th effector cells. Transplantation 80: 850-858
13. Gans, H. A., L. L. Yasukawa, C. Z. Zhang, R. H. Wakim, M. Rinki, R. Dehovitz, and A. M. Arvin. 2008. Effects of interleukin-12 and interleukin-15 on measlesspecific T-cell responses in vaccinated infants. Viral Immunol. 21: 163-172
14. Jain, A., T. P. Atkinson, P. E. Lipsky, J. E. Slater, D. L. Nelson, and W. Strober. 1999. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J. Clin. Invest. 103: 1151-1158
15. Takahashi, N., K. Imanishi, H. Nishida, and T. Uchiyama. 1995. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J. Immunol. 155: 5213-5219
16. Takahashi, N., H. Kato, K. Imanishi, K. Miwa, S. Yamanami, H. Nishida, and T. Uchiyama. 2000. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J. Clin. Invest. 106: 1409-1415
17. Lewis, R. S. 2001. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19: 497-521
18. Smith-Garvin, J. E., G. A. Koretzky, and M. S. Jordan. 2009. T cell activation. Annu. Rev. Immunol. 27: 591-619
19. Schubert, L. A., G. King, R. Q. Cron, D. B. Lewis, A. Aruffo, and D. Hollenbaugh. 1995. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J. Biol. Chem. 270: 29624-29627
20. Tsytsykova, A. V., E. N. Tsitsikov, and R. S. Geha. 1996. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J. Biol. Chem. 271: 3763-3770
21. Penix, L. A., M. T. Sweetser, W. M. Weaver, J. P. Hoeffler, T. K. Kerppola, and C. B. Wilson. 1996. The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J. Biol. Chem. 271: 31964-31972
22. Macián, F., C. López-Rodríguez, and A. Rao. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20: 2476-2489
23. Macián, F., F. García-Cózar, S.-H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731
24. Macián, F., C. García-Rodríguez, and A. Rao. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 19: 4783-4795
25. Sato, K., H. Nagayama, and T. A. Takahashi. 1999. Aberrant CD3- and CD28- mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity. J. Immunol. 162: 4464-4471
26. Miscia, S., A. Di Baldassarre, G. Sabatino, E. Bonvini, R. A. Rana, M. Vitale, V. Di Valerio, and F. A. Manzoli. 1999. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes. J. Immunol. 163: 2416-2424
27. Chandok, M. R., and D. L. Farber. 2004. Signaling control of memory T cell generation and function. Semin. Immunol. 16: 285-293
28. Cron, R. Q., L. A. Schubert, D. B. Lewis, and C. C. Hughes. 1997. Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes. J. Immunol. Methods 205: 145-150
29. Oh-hora, M., and A. Rao. 2008. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 20: 250-258
30. Marcolino, I., G. K. Przybylski, M. Koschella, C. A. Schmidt, D. Voehringer, M. Schlesier, and H. Pircher. 2004. Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history. Eur. J. Immunol. 34: 2672-2680
31. Haines, C. J., T. D. Giffon, L.-S. Lu, X. Lu, M. Tessier-Lavigne, D. T. Ross, and D. B. Lewis. 2009. Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J. Exp. Med. 206: 275-285
32. Atherfold, P. A., M. S. Norris, P. J. Robinson, E. W. Gelfand, and R. A. Franklin. 1999. Calcium-induced ERK activation in human T lymphocytes. Mol. Immunol. 36: 543-549
33. Franklin, R. A., P. A. Atherfold, and J. A. McCubrey. 2000. Calcium-induced ERK activation in human T lymphocytes occurs via p56(Lck) and CaM-kinase. Mol. Immunol. 37: 675-683
34. Nunès, J. A., Y. Collette, A. Truneh, D. Olive, and D. A. Cantrell. 1994. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J. Exp. Med. 180: 1067-1076
35. Li, Q.-J., J. Chau, P. J. R. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161
36. Cuesta, R., A. Martínez-Sánchez, and F. Gebauer. 2009. miR-181a regulates capdependent translation of p27(kip1) mRNA in myeloid cells. Mol. Cell. Biol. 29: 2841-2851
37. Bandyopadhyay, S., M. Duré, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macián. 2007. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. Blood 109: 2878-2886
38. Anandasabapathy, N., G. S. Ford, D. Bloom, C. Holness, V. Paragas, C. Seroogy, H. Skrenta, M. Hollenhorst, C. G. Fathman, and L. Soares. 2003. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18: 535-547
39. Jeon, M.-S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. Elly, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177
40. Bandyopadhyay, S., N. Soto-Nieves, and F. Macián. 2007. Transcriptional regulation of T cell tolerance. Semin. Immunol. 19: 180-187
41. Roederer, M., M. Bigos, T. Nozaki, R. T. Stovel, D. R. Parks, and L. A. Herzenberg. 1995. Heterogeneous calcium flux in peripheral T cell subsets revealed by five-color flow cytometry using log-ratio circuitry. Cytometry 21: 187-196
42. Weerkamp, F., E. F. de Haas, B. A. Naber, W. M. Comans-Bitter, A. J. Bogers, J. J. van Dongen, and F. J. Staal. 2005. Age-related changes in the cellular composition of the thymus in children. J. Allergy Clin. Immunol. 115: 834-840
43. Kohler, S., and A. Thiel. 2009. Life after the thymus: CD31+ and CD312 human naive CD4+ T-cell subsets. Blood 113: 769-774
44. Hassan, J., and D. J. Reen. 1998. IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur. J. Immunol. 28: 3057-3065
45. Webb, L. M., B. M. Foxwell, and M. Feldmann. 1997. Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production. Eur. J. Immunol. 27: 633-640
46. Li, G., M. Yu, W.-W. Lee, M. Tsang, E. Krishnan, C. M. Weyand, and J. J. Goronzy. 2012. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat. Med. 18: 1518-1524
47. Thornton, C. A., J. W. Upham, M. E. Wikström, B. J. Holt, G. P. White, M. J. Sharp, P. D. Sly, and P. G. Holt. 2004. Functional maturation of CD4 +CD25+CTLA4+CD45RA+ T regulatory cells in human neonatal T cell responses to environmental antigens/allergens. J. Immunol. 173: 3084-3092
48. Fei, J., Y. Li, X. Zhu, and X. Luo. 2012. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS ONE 7: e32834
49. Galluzzi, L., E. Morselli, I. Vitale, O. Kepp, L. Senovilla, A. Criollo, N. Servant, C. Paccard, P. Hupé, T. Robert, et al. 2010. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res. 70: 1793-1803
50. Bai, H., Z. Cao, C. Deng, L. Zhou, and C. Wang. 2012. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis. J. Cancer Res. Clin. Oncol. 138: 595-602
51. Ouyang, Y.-B., Y. Lu, S. Yue, and R. G. Giffard. 2012. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 12: 213-219
52. Lwin, T., J. Lin, Y. S. Choi, X. Zhang, L. C. Moscinski, K. L. Wright, E. M. Sotomayor, W. S. Dalton, and J. Tao. 2010. Follicular dendritic celldependent drug resistance of non-Hodgkin lymphoma involves cell adhesionmediated Bim down-regulation through induction of microRNA-181a. Blood 116: 5228-5236
53. Gajewski, T. F., D. Qian, P. Fields, and F. W. Fitch. 1994. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA 91: 38-42
54. Morton, A. M., B. McManus, P. Garside, A. M. Mowat, and M. M. Harnett. 2007. Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. J. Immunol. 179: 8026-8034
55. Doherty, M., D. G. Osborne, D. L. Browning, D. C. Parker, and S. A. Wetzel. 2010. Anergic CD4+ T cells form mature immunological synapses with enhanced accumulation of c-Cbl and Cbl-b. J. Immunol. 184: 3598-3608
56. Chiodetti, L., S. Choi, D. L. Barber, and R. H. Schwartz. 2006. Adaptive tolerance and clonal anergy are distinct biochemical states. J. Immunol. 176: 2279-2291
57. Kamal, M., A. Pawlak, F. BenMohamed, A. Valanciuté, K. Dahan, M. Candelier, P. Lang, G. Guellaën, and D. Sahali. 2010. C-mip interacts with the p85 subunit of PI3 kinase and exerts a dual effect on ERK signaling via the recruitment of Dip1 and DAP kinase. FEBS Lett. 584: 500-506
58. Chen, C.-H., W.-J. Wang, J.-C. Kuo, H.-C. Tsai, J.-R. Lin, Z.-F. Chang, and R.-H. Chen. 2005. Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 24: 294-304
59. Chuang, Y.-T., L.-W. Fang, M.-H. Lin-Feng, R.-H. Chen, and M.-Z. Lai. 2008. The tumor suppressor death-associated protein kinase targets to TCR-stimulated NF-kappa B activation. J. Immunol. 180: 3238-3249
60. Noël, G., C. Brinster, G. Semana, and D. Bruniquel. 2009. Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive. Int. Immunol. 21: 1025-1036
61. White, G. P., P. M. Watt, B. J. Holt, and P. G. Holt. 2002. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J. Immunol. 168: 2820-2827
62. Kadereit, S., G. R. Junge, T. Kleen, M. M. Kozik, B. A. Kaminski, K. Daum- Woods, P. Fu, M. Tary-Lehmann, and M. J. Laughlin. 2003. Deficient IFNgamma expression in umbilical cord blood (UCB) T cells can be rescued by IFN-gamma-mediated increase in NFATc2 expression. J. Clin. Immunol. 23: 485-497
63. Naderi, N., A. A. Pourfathollah, K. Alimoghaddam, and S. M. Moazzeni. 2009. Cord blood dendritic cells prevent the differentiation of naïve Thelper cells towards Th1 irrespective of their subtype. Clin. Exp. Med. 9: 29-36
64. Trivedi, H. N., K. T. HayGlass, V. Gangur, J. G. Allardice, J. E. Embree, and F. A. Plummer. 1997. Analysis of neonatal T cell and antigen presenting cell functions. Hum. Immunol. 57: 69-79
65. Chang, J. F., C. A. Thomas, III, and J. T. Kung. 1991. Induction of high level IL- 2 production in CD4+8- T helper lymphocytes requires post-thymic development. J. Immunol. 147: 851-859